42 reports of this reaction
1.6% of all PETROLATUM reports
#15 most reported adverse reaction
CELLULITIS is the #15 most commonly reported adverse reaction for PETROLATUM, manufactured by Aldermed Inc.. There are 42 FDA adverse event reports linking PETROLATUM to CELLULITIS. This represents approximately 1.6% of all 2,672 adverse event reports for this drug.
Patients taking PETROLATUM who experience cellulitis should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
CELLULITIS is a less commonly reported adverse event for PETROLATUM, but still significant enough to appear in the safety profile.
In addition to cellulitis, the following adverse reactions have been reported for PETROLATUM:
The following drugs have also been linked to cellulitis in FDA adverse event reports:
CELLULITIS has been reported as an adverse event in 42 FDA reports for PETROLATUM. This does not prove causation, but indicates an association observed in post-market surveillance data.
CELLULITIS accounts for approximately 1.6% of all adverse event reports for PETROLATUM, making it a notable side effect.
If you experience cellulitis while taking PETROLATUM, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.